| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85f8ff189acde80eebb96be11799092d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1919fcdba5d357b1e7ee74da1d544c8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_512db5e7086bf8994035d5502d5805b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_302e7f60271ac2581c9dec5a3d70ef8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a135a933620c99beab01d4ac785d25 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-02 |
| filingDate |
2002-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6a4ab5627752a956e86646f6dc4275c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c574bbab194885d1404c215980477b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d229f4f28ddb51342d6ec5f5a4a81251
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdbefed44a99f68436298a1ae19fc164 |
| publicationDate |
2003-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03000711-A1 |
| titleOfInvention |
Antimitotic eleuthesides |
| abstract |
This invention provides analogs of eleutherobin and the eleuthesides modified at the C-11 position or comprising an epoxide functionality from C-11 to C-12. C-11 to C-12 is an ideal location for conjugating functional moieties to the eleutherobin pharmacophore without significant loss of antimitotic activity. Moieties that may be conjugated at C-11 include those intended to increase the solubility of the pharmacophore, to facilitate drug formulation, or to facilitate in vivo delivery or targeting. |
| priorityDate |
2001-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |